Albureks (albumin) 200% 50 ml Solution

ALBUREKS 20, 200 g/l infusion solution for intravenous use

Albureks 20, international non-proprietary name: Human albumin.

ALBUREKS 20 composition

Active substance: 200 g of human plasma protein per 1 liter of solution, of which at least 96% is human albumin. Each ml contains approximately 3.2 mg sodium (140 mmol/l).

ALBUREKS 20, indications

Restoration and maintenance of circulating blood volume in cases of deficiency of circulating blood volume and when the use of colloidal solutions is indicated.

Contraindications

Hypersensitivity to albumin preparations or to any of the excipients.

Use during pregnancy and lactation

During pregnancy, harmful effects of Albureks 20 on the fetus or newborn have not been proven. Nevertheless, it should be used based on the benefit/risk ratio.

ALBUREKS 20, method of administration

For intravenous administration. The concentration, dosage regimen, and infusion rate should be selected individually depending on the patient’s condition. The infusion rate should not usually exceed 1–2 ml/min. The solution is ready for use and may be diluted with 5% glucose or 0.9% sodium chloride. It must not be diluted with water for injection.

Side effects

Rare: flushing, urticaria, fever, nausea. Very rare: anaphylactic shock. If the dose or rate is exceeded, hypervolemia and its consequences may occur.